Evaluating self-efficacy as a treatment mechanism during an intensive treatment program for posttraumatic stress disorder

Abstract: Objective: Although traumatic exposures are common, only a small percentage of people exposed to trauma go on to develop posttraumatic stress disorder (PTSD). This phenomenon suggests that there may be psychological factors that influence posttraumatic recovery trajectories. Beliefs about one's ability to cope with traumatic events have been proposed as a mechanism of posttraumatic recovery. The present study evaluated coping self-efficacy (CSE) as a treatment mechanism. Method: Data were collected from 423 military service members and veterans who completed a 2-week cognitive processing therapy-based intensive treatment program for PTSD. Linear mixed-effects models were used to evaluate the associations between CSE and clinical symptoms over time. CSE and clinical symptoms were assessed at baseline, every other day during treatment, and at posttreatment. In addition, general self-efficacy (GSE) was assessed at baseline and included in the analyses. Results: Participants reported that increases in CSE began early and steadily increased across all domains during treatment. In addition, decreases in PTSD and depression severity also began early and steadily decreased during treatment. Although improvements in CSE predicted decreases in clinical symptoms, changes in CSE did not precede clinical improvement. Baseline GSE was a significant predictor of clinical outcomes, but changes in clinical symptoms during treatment did not differ based on one's baseline GSE. Conclusions: The present study demonstrated that although changes in CSE do not temporarily precede changes in clinical symptoms, changes in CSE predicted changes in clinical symptoms, suggesting that CSE may serve as an indicator of treatment response.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.